V

Verseau Therapeutics

7 employees

Verseau focus is building a pipeline of first-in-class therapies that modulate macrophages to trigger a coordinated immune attack on cancer.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Therapeutics

Date founded

2017

Funding rounds raised

Total raised

$50M

from 2 investors over 2 rounds

V

Verseau Therapeutics raised $50M on October 21, 2019

Investors: 20/20 HealthCare Partners and 上海涌铧投资管理有限公司

FAQ